Clinical Trial

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults

Study acronym: PRO-CNS
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated June 13, 2016 (before its estimated July 2020 completion). Its status may not reflect the trial's current state.
Summary
Open label, multi-centre prospective study. Adult patients with primary central nervous system tumours fulfilling the inclusion criteria according to the study protocol. The study consists of 2 sequential cohorts evaluated consecutively for the feasibility, safety and toxicity, as well as long-term survival data, when using spot scanning proton beam therapy.
Trial Details
NCT Number NCT02797366
Lead Sponsor Uppsala University
Collaborators: Sahlgrenska University Hospital, Karolinska University Hospital, University Hospital, Umeå, Region Örebro County, University Hospital, Linkoeping
Conditions Central Nervous System Tumour, Arteriovenous Malformation
Enrollment 500 participants
Start Date 2015-08
Primary Completion 2020-07 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2016-06-13